The Zacks Analyst Blog Highlights: Bayer, Johnson & Johnson, Netflix, Lions Gate Entertainment and Google - Press Releases
For Immediate Release
Chicago, IL - November 23, 2011 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Bayer ( BAYRY ), Johnson & Johnson ( JNJ ), Netflix Inc. ( NFLX ) , Lions Gate Entertainment Corp. ( LGF ) and Google Inc. ( GOOG ) .
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Tuesday's Analyst Blog:
Bayer Cut to Underperform
We recently downgraded Bayer ( BAYRY ) to Underperform from Neutral purely on valuation grounds. We believe that the stock is overvalued at current levels.
Even though the US Food and Drug Administration (FDA) cleared Bayer/ Johnson & Johnson 's ( JNJ ) potential blockbuster blood thinner Xarelto for stroke prevention in atrial fibrillation (SPAF) earlier in the month, the associated warning that discontinuation of the drug increases the risk of stroke in SPAF patients could hamper its sales. Below-par showing by Xarelto could pull down the stock significantly. Moreover, the presence of Boehringer Ingelheim's Pradaxa (approved by the FDA in 2010) has intensified competition in the market.
Moreover, Bayer delivered average results in the third quarter of 2011 with key drugs such as Betaferon, Kogenate and Levitra not performing well. Sales in the Pharmaceutical segment were flat due to weakness in the North American and Western European markets because of healthcare reforms in those territories. Continued weak performance in the key markets could also pull down the stock. Moreover, the limited near-term catalysts at Bayer also concern us. We have reduced our 2011 and 2012 earnings estimates by $0.16 and $0.46 per ADS, respectively.
Furthermore, Bayer, which operates through three major segments- Healthcare, Material Science and Crop Science - has been looking to strengthen its HealthCare segment. The company has been inking deals/making acquisitions to achieve the objective. For example, in September 2011, Bayer purchased Kirkland, Washington based Pathway Medical Technologies, Inc. to strengthen its HealthCare segment. Moreover, in early 2011 Bayer inked a deal with Zydus Cadila to strengthen its pharmaceutical operations in one of the most sought after markets - India. However, if these initiatives fail to deliver the desired results due to integration risks associated with mergers, then it will weigh heavily on the stock.
These negative factors cause us to believe that the stock is overvalued and there is little reason for investors to own the stock at current levels.
Netflix to Raise $400 Million
Netflix Inc. ( NFLX ) recently announced that it will raise $400.0 million by issuing common equity and convertible notes. The video rental and online streaming provider expects the issuance of common equity and convertible notes to generate proceeds of approximately $397.0 million, after deducting offering expenses.
Netflix will raise $400.0 million from two premier investors namely T. Rowe Price Associates, Inc. and Technology Crossover Ventures (TCV). Netflix sold 2.86 million of common stock at $70.00 per share to certain mutual funds and accounts managed by T. Rowe Price Associates, Inc. On the other hand, TCV bought zero coupon convertible senior notes of the company maturing 2018 for $200.0 million in a private placement.
We believe that the cash infusion will help Netflix pursue its global expansion policy. The company is venturing into the uncharted areas of the United Kingdom and Ireland and has already announced a number of partnerships with premier Hollywood studios such as Metro-Goldwyn-Mayer Studios Inc., Lions Gate Entertainment Corp. ( LGF ) and Miramax Studios.
In the third quarter of 2011, the company also ventured into Latin America and the Caribbean, where it teamed up with local content providers for regional language programs. We believe the strategy to expand internationally will be accretive for Netflix over the long term and provide the necessary platform for raising its profitability on a global basis, as the company significantly diversifies the risk of customer concentration in a particular region.
However, we believe that the International operations will take some time to contribute significantly to the company's top-line and bottom-line growth. Moreover, the company has faced significant criticism in the U.S. due to the increase in DVD prices and its initial decision of splitting its operations into two and subsequent backtracking. Netflix lost approximately 800,000 subscribers during the third quarter.
Although the company foresees a profitable fourth quarter of 2011, subscriber growth is expected to remain flat. Netflix forecasts several quarters of losses starting from the first quarter of 2012, as domestic profits are not expected to be high enough to compensate the expected losses from expansion into international markets. Netflix is expecting a net loss for the fiscal year ending December 31, 2012, primarily attributable to relatively flat consolidated revenues and increased investment in the International segment.
We believe that the proceeds from the transaction will also help Netflix to expand its streaming library, particularly in its domestic market, which will attract new subscribers going forward. However, an increasing debt level remains a concern, in our view. As of September 30, 2011 Netflix had cash and cash equivalents of $365.8 million versus a long-term debt of $200.0 million.
Further, the multi-year contracts with the studios will require Netflix to pay approximately $3.5 billion for the rights to stream video over the long term. Netflix also expects these costs to increase going forward, which will remain a significant overhang on the stock in our view.
Additionally, intensifying competition from large players such as Google Inc. ( GOOG ) in the online streaming market is also a headwind, as it will further escalate license fees and also affect subscriber additions over the long term.
We have an Underperform recommendation on Netflix over the long term (6-12 months). Currently, Netflix has a Zacks #3 Rank, which implies a Hold rating in the short term.
Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=5515 .
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=5517
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leon Zacks. As a PhD from MIT Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=5518 .
Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
BAYER A G -ADR ( BAYRY ): Free Stock Analysis Report
GOOGLE INC-CL A ( GOOG ): Free Stock Analysis Report
JOHNSON & JOHNS ( JNJ ): Free Stock Analysis Report
LIONS GATE ETMT ( LGF ): Free Stock Analysis Report
NETFLIX INC ( NFLX ): Free Stock Analysis Report
Zacks Investment Research